Clot Management Devices Market To Reach $2.53 Billion By 2030

Clot Management Devices Market Growth & Trends

The global clot management devices market size is expected to reach USD 2.53 billion by 2030, advancing at a CAGR of 5.0% during the forecast period, according to a new report by Grand View Research, Inc. The market growth is driven by several factors, including an increase in the prevalence of cardiovascular diseases, a rise in geriatric population, and advancements in medical technology. The demand for these devices is also fueled by the growth in awareness among healthcare professionals and patients regarding the benefits of effective clot management in preventing serious health complications.

The rising incidence of cardiovascular diseases has fueled market demand. As the population ages, the risk factors associated with blood coagulum formation increase, highlighting the need for effective solutions. Healthcare providers are seeking advanced devices to address the growing burden of CVDs and mitigate coagulum-related risks. Technological advancements in clot management devices have also driven market growth. Innovations such as catheters, filters, and stents are being developed to enhance coagulum retrieval and dissolution capabilities. Continued development of cutting-edge technologies in the field has boosted adoption rates and propelled market growth.

The COVID-19 pandemic strongly impacted the market by raising awareness of the increased blood coagulum risk associated with the virus. Healthcare providers have increasingly utilized clot retrieval devices to treat COVID-19 patients with severe lung involvement and clot-related complications, improving patient outcomes. Increased awareness of clot management's importance is poised to have long-lasting effects on healthcare systems prioritizing the prevention and management of coagulum-related complications. The market is poised to witness sustained growth as healthcare providers address challenges posed by the pandemic and prioritize comprehensive patient care.

 Request a free sample copy or view report summary: Clot Management Devices Market Report

Clot Management Devices Market Report Highlights

• Based on product, the percutaneous thrombectomy devices segment held the largest revenue share in 2022, as it is used in minimally invasive procedures for removing blood clots, which appeals to both patients and healthcare providers. The segment's dominance can also be attributed to advancements in technology, such as the development of innovative devices and improved efficacy in clot removal, leading to higher adoption rates and demand for percutaneous thrombectomy devices

• Based on end-use, the market for clot management devices has been categorized into diagnostic centers and hospitals. The hospitals segment accounted for the largest revenue share in 2022. Hospitals serve as the primary point of care for patients requiring clot management, providing initial evaluation, diagnosis, and treatment recommendations. They have dedicated committees and teams for selecting medical devices and collaborating with different entities in the value chain to access clot management devices

• The North American region accounted for the largest revenue share of 59.73% in 2022 and is expected to dominate the market. North America has a well-developed, advanced healthcare infrastructure, including hospitals, clinics, and medical facilities; additionally, the rising prevalence of cardiovascular diseases and an aging population further drive product demand in North America

Clot Management Devices Market Segmentation

Grand View Research has segmented the global clot management devices marketon the basis of product, end-user, and region:

Clot Management Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• Neurovascular Embolectomy Devices

• Embolectomy Balloon Catheters

• Percutaneous Thrombectomy Devices

• Catheter-Directed Thrombolysis (CDT) devices

• Inferior vena cava filters (IVCF)

Percutaneous Thrombectomy Devices Type Outlook (Revenue, USD Million, 2018 - 2030)

• Aspiration Thrombectomy Devices

• Percutaneous Mechanical Thrombectomy Devices

Clot Management Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Diagnostic centers

• Hospitals

Clot Management Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Norway

  • Denmark

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa

  • Saudi Arabia

  • South Africa

  • UAE

  • Kuwait

List of Key Players in the Clot Management Devices Market

• Medtronic

• Boston Scientific Corporation

• iVascular SLU

• Teleflex Inc

• Edwards Lifesciences Corporation

• LeMaitre Vascular, Inc

• Vascular Solutions, Inc

• Straub Medical AG

• Cook Medical

• DePuy Synthes